StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Systemic Lupus Erythematosus - Essay Example

Cite this document
Summary
This essay "Systemic Lupus Erythematosus" discusses Systemic Lupus Erythematosus (SLE), Disseminated lupus erythematosus, Discoid lupus or lupus as a remarkable disease in many aspects; the primary being it is not a single but a protean disease, affecting almost every organ of the body…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER93.6% of users find it useful
Systemic Lupus Erythematosus
Read Text Preview

Extract of sample "Systemic Lupus Erythematosus"

SYSTEMIC LUPUS ERYTHEMATOSUS INTRODUCTION Systemic Lupus Erythematosus (SLE), Disseminated lupus erythematosus, Discoid lupus or lupus is a remarkable disease in many aspects; the primary being it is not a single but a protean disease, affecting almost every organ of the body. Second, despite the apparently normal condition of the affected individuals, the disease is fatal and is manifested in form of multiple clinical symptoms associated with other diseases. Finally the disease affects individual of younger ages, who can only be diagnosed up to five years after the appearance of the first set of symptoms (Rahman & Isenberg, 2008), however early diagnosis is the key factor improving prognosis (D’Cruz, 2006). DISEASE DESCRIPTION Pathophysiology SLE is a chronic, inflammatory, prototypic, systemic autoimmune disease affecting connective tissues such as skin, joints along with kidney and serosal membranes. Researches available indicate an environmental cause, which leads to development of the disease in individuals genetically predisposed and therefore vulnerable to it. However, the disease epidemiology is incompletely understood (Rahman & Isenberg, 2008). The disease involves the production of IgG autoantibodies that are specific for self antigens including DNA, nuclear proteins as well as cytoplasmic components. The disease therefore is characterized by inflammation, vasuclitis, vasculopathy. Further, a deposition of the immune complex especially in the renal glomeruli leads to a systemic inflammatory response through activation of complement (C5), or of Fc{gamma}R-mediated neutrophil and macrophages. While the activation of former leads to formation of membrane attack complexes (C5b-9) or anaphylatoxin and cell activator C5a; that of latter causes release of oxidants and proteases; both leading to injury (KEGG, 2009). The mechanism of the disease development has been proposed to involve an abnormal apoptosis followed by elevated levels of cell death and immune intolerance. Cellular antigen redistribution to the cell surface coupled with lymphocytes targeting them leads to injury and inflammation (Andrade et al., 2000). Treatment Diagnosis of SLE is based on the detection of high levels of antinuclear and other antibodies in the blood along with symptoms of SLE. The techniques used for the detection include urinalysis, CBC, ESR, complement levels, ANA (antinuclear antibody test) and other antibody tests, skin and kidney biopsy along with quarterly follow ups. The treatment involves control of disease symptoms and is determined by the severity of the symptoms. Acute SLE involving CNS, cardiovascular and renal diseases are treated with high doses of intravenous steroids and cytotoxic therapy involving corticosteroids, immunosuppresives, antimalarials, and antipsychotic medication (D’Cruz, 2006). Prognosis Early detection is the key factor in improved prognosis of SLE. Prognosis in severe cases too has shown marked improvement during the recent years as a consequence of aggressive treatments available. Common complications associated with SLE include deep vein thrombosis, pulmonary embolism, hemolytic anemia, pericarditis, endocarditis, myocarditis etc (Makover, 2011). Health Disparity SLE exhibits high correlation with women of child bearing age and therefore has been associated with exogenous hormone intake (Costenbader et al., 2007). Lower socioeconomic status further has been linked to higher disease prevalence as well as resultant mortality. Prevalence and Epidemiology The National Arthritis Data Working Group reports that approximately 250,000 Americans have SLE, the worldwide prevalence rates vary with race, being higher in people with African and Asian origins. The disease is more common in the female sex and in individuals within the age group of 20-40yrs. (D’Cruz, 2006). Organizational Description of the Facility The ER, Fast Track, department known as Rapid Medical Screening (RMS) clinic, of the Medical Center of Central Georgia (MCCG), is where I am currently doing my clinical practicum. MCCG is titled a Level I Trauma Center and Magnet™ hospital, aiding the citizens of Central and South Georgia. MCCG’s licensed capacity is 637 beds, comprising of pediatric, obstetric, medical-surgical, intensive care (pediatric, cardiac, neurology, cardiac surgery), and psychiatric. The company serves an appraised population of 750,000 residents and is now the second largest hospital in the state of Georgia. MCCG characteristically treats patients from approximately 80 percent of Georgia’s 159 counties. The mission statement does not directly address SLE, but generally stated, there mission is to provide reasonably priced health care services to the Central and South Georgia community that is comprehensive in range and high-quality. Payment sources for patients include self-pay, indigent, private insurance, Medicaid and Medicare. Technologies used by this clinic to promote safe practice AngioScreen®, MAKOplasty®, SILS™, Endobronchial ultrasound (EBus), superDimension® Electromagnetic Navigation Bronchoscopy system (ENB), and TRU-D™ Rapid Room Sterilization. When it comes to statistical data, no clinical evidence was found to identify the SLE population percentage of using MCCG RMS department. Clinical preceptor, S.B. FNP, stated that it was very rare to actually diagnosis a patient with lupus, without have a long standing rapport and accurate history and physical findings. RMS is commonly used by uninsured patients who may only disclose necessarily what currently is affecting them (MCCG, 2011). CURRENT EVIDENCE-BASED STATUS A recent study conducted by Javierre and colleagues (2010) to study the changes in the pattern of DNA methylation associated with twin discordance in SLE. Monozygotic twins have been reported to be partially concordant for most of the complex diseases including autoimmune disorders. A 100% concordance results due to inheritance of the mutant gene in both of the identical twins indicating that the mutant allele is dominant and highly penetrant. Thus while concordance can be a consequence of heritability, discordance can be employed as a tool for investigation of non-genetic factors. The two major epigenetic factors influencing phenotypic outcomes by regulating gene expression and hence providing alternate pathways of gene function alteration are DNA methylation and histone modification. While epigenetic factors modulate gene functions, they themselves are reportedly dependent on environmental factors such as diet. Alleles identified to be involved in SLE development have been located in the major histocompatibilty complex region, IRFS, STAT4, BLK, BANK1 PDCD1, MECP2, and TNSF4 etc. Most of these genes are also involved in other autoimmune disorders such as rheumatoid arthritis (RA) and dermatomyositis. Besides the genes, epigenetic events such as promoter demethylation of these genes have also been established in lymphocytes of SLE patients. Investigation on monozygotic twins can provide remarkable tool for investigation of epigenetic effects since there is no interference on account of varying DNA sequences including single- nucleotide polymorphisms (SNPs). The study was designed based on the above rationale to investigate the epigenetic factors, specifically DNA methylation pattern in monzygotic twins with discordance for SLE. A group of identical twins discordant for SLE, RA and dermatomyositis; were compared and DNA methylation patterns were studied in them. DNA methylation profiling was conducted using universal bead arrays on 60 DNA samples obtained from the white blood cells of 30 identical twins, along with 30 unrelated age, gender and race matched normal controls. While no differences in DNA methylation patterns were observed in 5 of the twins discordant for RA and dermatomyositis, a difference was observed in SLE discordant 5 identical twins. A common set of genes 49 in number exhibited differential DNA methylation patterns in the SLE affected twin compared to the normal twin. No significant differential methylation was observed in these 49 genes in the five pairs of unrelated normal controls involved in the study. These 49 genes were found to be involved in defense response, cell activation, cell proliferation, immune response and cytokine production. These are the processes affected I the pathogenesis of SLE, providing further evidence of their involvement in SLE. Further the study also investigated the nature of changes brought about in the gene expression as a consequence of altered DNA methylation patterns of the gene promoters. It has been established by prior studies that a global loss in methylation levels can be linked to development of SLE and RA. However, the researchers in this study when attempted to establish the same, by estimating the levels of 5-methylcytosine, found significantly lower levels of DNA methyltransferases (DNMTs), but no changes at Alu, Satellite2, D4Z4 and NBL2 repeats. The study also investigated the three regions of ribosomal RNA gene cluster i.e. the ribosomal gene promoter, 18S and 28S. Significant differences in methylation levels were observed in 18S and 28S regions in the SLE affected twin compared to normal. While the healthy sibling had same levels of methylation as matched controls, the SLE discordant twin exhibited lower levels of methylation in these segments. Though these changes occur downstream to transcription start site, they were observed to increase transcript levels. The significance of use of monozygotic twins for studies involving epigenetic factors was established by this study. The lower levels of methylation of several genes can have important implications in context with prior studies. These studies have reported the association of hypomethylation at key CpGs promoters of genes such as interferon gamma and cytokine genes with lymphocyte activation and differentiation. The study provided the evidence for epigenetic differences in identical twins with discordance of SLE, however whether these differences are responsible for the development of the disease or vice versa could not be established. The study also provided evidence that the epigenetic factors become more pronounced with advancing age. Future Research Major advances in the understanding and treatment of SLE are possible with further research in the field. Despite early diagnosis and improvements in prognosis, the quality of life of SLE patients still remains difficult due to high levels of corticosteroids involved in the treatment procedures, fatigue, infections and cardiovascular risks. Future research should be aimed at development of treatments that can help me better disease management as well as improved prognosis. Clinical trials need to be conducted to evaluate the efficacy of peptides, monoclonal antibodies such as Rituximab and biological agents such as abatacept (CTLA4Ig) and epratuzmab in lupus (D’Cruz, 2006). The Genetic aspects of the disease are as significant as incompletely understood. It is imerative to understand the association fo genes with physiological control of geen responses which become aberrant in SLE. Study of ubiqiutination and methyaltion as mechanisms underlying control of gene expression needs to be further investigated (Rhodes & Vyse, 2008). REFERENCES 1. Andrade, F, L Casciola-Rosen and A. Rosen. "Apoptosis in systemic lupus erythematosus. Clinical implications." Rheum Dis Clin North Am (2000): 215-27. 2. Costenbader, K. H, et al. "Reproductive and menopausal factors and risk of systemic lupus erythematosus in women." Arthritis Rheum (2007): 1251-62. 3. DCruz, D. P. "Systemic lupus erythematosus." BMJ (2006 ): 890-4. 4. Javierre, B. M, A. F Fernandez and J. Richter et al.. "Changes in pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus." Genome Research (2010): 170-9. 5. KEGG. "Systemic lupus erythematosus - Homo sapiens (human)." 2009. GenomeNet. 12 July 2011 . 6. Makover, M. E. "Systemic lupus erythematosus." 2011. PubMed Health. July 2011 . 7. MCCG. About MCCG. 15 June 2011 . 8. Rahman, A and D. A. Isenberg. " Systemic lupus erythematosus." N Engl J Med (2008): 929-39. 9. Rhodes, B and T. J. Vyse. "The genetics of SLE: an update in the light of genome wide association studies." Rheumatology (2008): 1603-11. Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Systemic Lupus Erethematotus Essay Example | Topics and Well Written Essays - 1500 words - 1”, n.d.)
Systemic Lupus Erethematotus Essay Example | Topics and Well Written Essays - 1500 words - 1. Retrieved from https://studentshare.org/nursing/1578152-systemic-lupus-erethematotus
(Systemic Lupus Erethematotus Essay Example | Topics and Well Written Essays - 1500 Words - 1)
Systemic Lupus Erethematotus Essay Example | Topics and Well Written Essays - 1500 Words - 1. https://studentshare.org/nursing/1578152-systemic-lupus-erethematotus.
“Systemic Lupus Erethematotus Essay Example | Topics and Well Written Essays - 1500 Words - 1”, n.d. https://studentshare.org/nursing/1578152-systemic-lupus-erethematotus.
  • Cited: 0 times

CHECK THESE SAMPLES OF Systemic Lupus Erythematosus

Running Head: Novel Treatment of Lupus Erythematosis

Introduction Systemic Lupus Erythematosus is one of the many forms of Lupus (immune system diseases).... Leandro and Edward (2006) explain that when it only affects the skin, it is referred to as Lupus dermatitis, and if it affects the internal organs only, it is called Systemic Lupus Erythematosus.... The novel treatment for Systemic Lupus Erythematosus is managed by immunosuppressive drugs like cyclophosphamide, methotrexate and corticosteroids....
3 Pages (750 words) Essay

Ethical End of Life Decisions and Different Considerations

9 Pages (2250 words) Essay

Research on Systemic Lupus Erythematosus

The review "Research on Systemic Lupus Erythematosus" focuses on the critical analysis of the Systemic Lupus Erythematosus.... Based on previous studies with Systemic Lupus Erythematosus, or SLE, the disease is believed to be treated using drugs that suppress the immune system.... Secondary data which were measured immediately upon admission into the experimental study included the Systemic Lupus Erythematosus Disease Activity Index, or SLEDAI, the lupus serology test results as determined by the antinuclear antibody and anti-double-stranded DNA antibody, the test on complement C3 and C4, and the test on end-organ function determined by creatinine clearance, and the carbon monoxide diffusion lung capacity....
11 Pages (2750 words) Book Report/Review

The Impact, Causes, Symptoms, Treatment and Management of Systemic Lupus Erythematosus

The paper "The Impact, Causes, Symptoms, Treatment and Management of Systemic Lupus Erythematosus" states that for patients suffering from lupus, familial support is an essential component of recovery as lupus has an impact on all aspects of life like social and sexual activity.... lupus has a profound impact on the individual both physiologically and psychologically.... Patients diagnosed with lupus undergo a lot of suffering, but it is possible to help them by dealing with the symptoms and teaching them to go on with their lives....
10 Pages (2500 words) Research Paper

A Clinical Example of SLE presenting with Lupus Panniculitis of the Lower Extremities

This is a case of a 36 year-old female diagnosed with Systemic Lupus Erythematosus who presented with nodules on her lower extremities seen in lupus panniculitis and is rarely seen presenting in patients with SLE.... This is a rare disease which occurs as a separate entity or rarely along with Systemic Lupus Erythematosus.... upus panniculitis which is a variant of erythema nodosum or lupus erythematosus has close resemblance clinically and can only be differentiated histopathologically....
6 Pages (1500 words) Research Paper

Pathophysiology of Systemic Lupus Erythematosus

This essay "Pathophysiology of Systemic Lupus Erythematosus" will explore the pathophysiology relating to a call.... When questioned about her medical history, she stated she had a condition called Systemic Lupus Erythematosus.... On review of the patient's medical history revealed that the patient's ANA test had tasted positive at 1:640 and her LE cell pre or erythematosus test had been found to be negative(normal and negative test without LE cells)....
6 Pages (1500 words) Essay

Why Is There a Higher Prevalence of Lupus SLE Found Among Females of Afro Caribbean Origins

The author of the paper "Why Is There a Higher Prevalence of lupus SLE Found Among Females of Afro Caribbean Origins?... is of the view that lupus SLE is a medical condition that is difficult to diagnose, and treat.... People who are vulnerable to lupus SLE are women.... There are a variety of factors that is responsible for making these people be vulnerable to lupus SLE, and this includes the genetic makeup of women, environmental factors, and socio-economic factors....
15 Pages (3750 words) Literature review

Systemic Lupus Erythematosus

However, when the tolerance fades, Systemic Lupus Erythematosus may occur.... After years of advancing research into the causes, symptoms, and treatment of the disease, the health system seems to have The paper 'Systemic Lupus Erythematosus - Causes, Symptoms, Diagnosis, Complications, and Treatment" is a forceful example of a term paper on health sciences & medicine.... Systemic Lupus Erythematosus The body usually has in place self-tolerance that serves to ensure that the immune system does not trigger reaction against itself....
3 Pages (750 words) Term Paper
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us